1. Home
  2. ORC vs CRVS Comparison

ORC vs CRVS Comparison

Compare ORC & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orchid Island Capital Inc.

ORC

Orchid Island Capital Inc.

N/A

Current Price

$6.51

Market Cap

1.4B

Sector

Real Estate

ML Signal

N/A

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.31

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORC
CRVS
Founded
2010
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2011
2016

Fundamental Metrics

Financial Performance
Metric
ORC
CRVS
Price
$6.51
$14.31
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$7.50
$30.17
AVG Volume (30 Days)
3.9M
705.4K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
17.07%
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$21.28
N/A
Revenue Next Year
$5.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.31
$5.64
52 Week High
$8.40
$26.95

Technical Indicators

Market Signals
Indicator
ORC
CRVS
Relative Strength Index (RSI) 40.91 48.45
Support Level $6.42 $12.76
Resistance Level $7.00 $16.66
Average True Range (ATR) 0.09 0.63
MACD -0.01 -0.08
Stochastic Oscillator 3.23 24.38

Price Performance

Historical Comparison
ORC
CRVS

About ORC Orchid Island Capital Inc.

Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: